You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Actuated Low Stress Endotracheal Tube Cleaner to Improve Neonate Lung Function
SBC: ACTUATED MEDICAL, INC. Topic: NICHDDESCRIPTION provided by applicant This Phase II SBIR finalizes development and clinically tests Neo ET Clear an Actuated Low Stress Endotracheal Tube ETT Cleaner to Improve Neonate Lung Function Neo ET Clear suctions mucus from mm diameter neonatal endotracheal tubes with significantly reduced deleterious impact on lung function and mechanics as compared to current methods includin ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Advancement to Clinical Candidate of Novel, Potent and Selective Chikungunya virus inhibitor series
SBC: VENATORX PHARMACEUTICALS INC Topic: NIAIDDESCRIPTIONprovided by applicantNovel therapies for the treatment of Chikungunya virusCHIKVinfections are urgently needed to address the alarming spread of this pathogen across the AmericasWe have identified a series of potentselectiveand orally bioavailable inhibitors of CHIKV replicationIn this Direct to Phaseprojectwe will optimize this series of CHIKV inhibitors to Pre Development stage and ad ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
A mechanism based computational tool to optimize pulmonary drug delivery
SBC: CFD RESEARCH CORPORATION Topic: 300DESCRIPTION provided by applicant Pulmonary drug delivery has emerged as a noninvasive alternative route for the treatment of lung diseases asthma COPD CF and lung cancer In order to obtain the desired level of effectiveness and safety of the inhaled drugs an appropriate deposition on the targeted region and subsequent absorption in the targeted region is vital Multiscale multidisciplin ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
An Acoustofluidic Device for Point of Care Sputum Processing and Analysis
SBC: Ascent Bio-Nano Technologies Inc Topic: NHLBIProject Summary Asthma is a chronic lung disease that causes the airways in the lungs to become inflamed making it difficult to breathe and leading to episodes of intense coughing and wheezing The prevalence of asthma has increased rapidly over the past several decades and more than in Americans are now living with the disease While there is no cure for asthma the symptoms of the disease ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
A New Technique for Diabetic Foot Ulcers
SBC: Noveratech L.L.C. Topic: 200ABSTRACT Diabetes is the leading cause of nontraumatic lower extremity amputations in the United States Diabetic foot ulcers DFUs are responsible for more hospitalizations than any other diabetic complications Currently even the best available treatments achieve only a healing rate for these wounds and this healing is often only temporary with a chance of recurring Our company has ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Chemical Optimization of a novel class of USP inhibitor for cancer treatment
SBC: PROGENRA INC Topic: 102DESCRIPTION provided by applicant Numerous regulatory proteins are tightly controlled by ubiquitin conjugation and deconjugation and deviations from this dynamic process are manifested in clinical disorders such as cancer inflammation neurodegenerative disorders and metabolic diseases The deubiquitylase DUB USP plays multiple regulatory roles all of which are pro survival antiapoptotic ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Clinical study of aerosolized KL4 surfactant for neonatal RDS and BPD prevention
SBC: DISCOVERY LABORATORIES, INC. Topic: NHLBIDESCRIPTIONprovided by applicantDiscovery LaboratoriesIncDiscoveryis developing a novel drug device combination therapyAEROSURF rthat employs an optimized proprietary capillary aerosol generatorCAGto deliver aerosolized surfactantlucinactantto preterm infants with or at risk for respiratory distress syndromeRDSand who may subsequently develop a chronic lung disease known as bronchopulmonary dyspla ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Percutaneous DLC for Total Cavo pulmonary Assistance
SBC: W-Z BIOTECH LLC Topic: NHLBIDESCRIPTION provided by applicant The Fontan procedure or total cavopulmonary connection TCPC is a standard palliative surgery for patients with complex single ventricle congenital heart anomalies TCPC connects the inferior and superior vena cava IVC and SVC directly to the right pulmonary artery bypassing the heart The single ventricle is then reserved for pumping oxygenated blood to th ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF TOPICAL ANTIVIRAL AGENTS FOR TREATING MOLLUSCUM CONTAGIOSUM
SBC: FOX CHASE CHEMICAL DIVERSITY CENTER INC. Topic: NIAIDDESCRIPTIONprovided by applicantMolluscum contagiosumMCis a highly contagious skin disease caused by the poxvirusMCVMC appears as lesions on the body and face and can last months years before resolvingLesions occur most frequently in childrenand immune compromised individualsThe infection is confined to skin aloneit is not systemicTransmission spreads directly from person person contactautoinocula ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System
SBC: ABT Molecular Imaging Topic: 102DESCRIPTION provided by applicant Worldwide a person dies from cancer every seconds Positron emission tomography PET is an effective tool that is critical in diagnosing cancer and monitoring treatment efficacy PET imaging relies on use of short lived radioisotopes Commercial distribution of the most commonly used radio tracer F FDG has resulted in patient population coverage in ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health